Top 10 Mass Spectrometry Downloads for Clinical Scientists
Discover the application notes, scientific posters and compendiums being downloaded daily by clinical scientists
Discover the application notes, scientific posters and compendiums being downloaded daily by clinical scientists
Learn about best practices for immune monitoring assays using xMAP® Technology from Luminex
Prof. Dr. Ger Rijkers tells SelectScience how he is using Luminex xMAP Technology® to develop a multiplex assay that can identify specific antibodies to multiple serotypes of S. pneumoniae in a single test
Registration is now open for our interactive webinar which will present the key benefits and applications of single-cell sequencing
You can download this educational guide free of charge from EKF's new diabetes portal
New healing gel patch now at prototype stage, say scientists in Singapore
LiDia bloodstream infection test showcased at an Imperial College/Royal Institution Technology vs Infectious Diseases Summit in London
Glythera gains exclusive access to Cancer Research UK’s novel CDK11 inhibitor programme for the development of antibody drug conjugates
Revolutionary new chemistry analyzers said to offer flexibility, simplified workflow and tighter control gain CE Mark
Beckman Coulter to present at the European Society for Clinical Cell analysis (ESCCA) 2017
STA R Max2 improves HIL detection and gives greater confidence in sample integrity
Rigaku will attend the 2017 Materials Science and Technology meeting, promoting its latest X-ray analytical solutions
First-of-its-kind product has driven significant reimbursement in key markets, due to exceptional clinical outcome data and proven accuracy
Screening for C. Difficile will reduce number of avoidable deaths, writes guest editor Gosia Leitch, Global Product Director with Alere
Dendritic cells are a key contributor to developing cancer vaccines
New CRISPR screening services substantially broaden range of possible genetic studies
This exclusive interview reveals how Jackson have remained leaders in the secondary antibody market for over 30 years